NASDAQ: PTPI
Petros Pharmaceuticals Inc Stock Ownership - Who owns Petros Pharmaceuticals?

Insider buying vs selling

Have Petros Pharmaceuticals Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when PTPI insiders and whales buy or sell their stock.

PTPI Shareholders

What type of owners hold Petros Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
John D. Shulman56.95%5,703,544$1.91MInsider
Fady Boctor0.50%49,645$16.63kInsider
Ubs Group Ag0.44%44,221$14.81kInstitution
Geode Capital Management LLC0.37%37,517$12.57kInstitution
Two Sigma Securities LLC0.32%32,284$10.82kInstitution
Vanguard Group Inc0.32%31,811$10.66kInstitution
Blackrock Inc 10.16%16,128$5.40kInstitution
Joshua Silverman0.11%11,237$3.76kInsider
Bruce Bernstein0.08%8,346$2.80kInsider
Wayne Remell Walker0.08%8,314$2.79kInsider

1 of 3

PTPI vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PTPI1.66%57.83%
CTOR0.05%99.95%
QNTM6.59%0.00%
SNOA0.72%99.28%
CPHI0.08%99.92%

Petros Pharmaceuticals Stock Ownership FAQ

Who owns Petros Pharmaceuticals?

Petros Pharmaceuticals (NASDAQ: PTPI) is owned by 1.66% institutional shareholders, 57.83% Petros Pharmaceuticals insiders, and 40.51% retail investors. John D. Shulman is the largest individual Petros Pharmaceuticals shareholder, owning 5.70M shares representing 56.95% of the company. John D. Shulman's Petros Pharmaceuticals shares are currently valued at $1.91M.

If you're new to stock investing, here's how to buy Petros Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.